Abstract
Tumour hypoxia is significantly correlated with patient survival and treatment outcomes. At the molecular level, hypoxia is a major driving factor for tumour progression and aggressiveness. Despite the accumulative scientific and clinical efforts to target hypoxia, there is still a need to find specific treatments for tumour hypoxia. In this review, we discuss a variety of approaches to alter the low oxygen tumour microenvironment or hypoxia pathways including carbogen breathing, hyperthermia, hypoxia-activated prodrugs, tumour metabolism and hypoxia-inducible factor (HIF) inhibitors. The recent advances in technology and biological understanding reveal the importance of revisiting old therapeutic regimens and repurposing their uses clinically.
Subject
Molecular Biology,Biochemistry
Reference194 articles.
1. Targeting hypoxia in cancer therapy
2. Hypoxia, DNA repair and genetic instability
3. Radiobiology for the Radiologist;Hall,2006
4. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene;Comerford;Cancer Res.,2002
5. The impact of hypoxia and its modification of the outcome of radiotherapy
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献